Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

Advertising by Adpathway

Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy

2 days ago 7

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

Advertising by Adpathway

Merck KGaA drug Pimjetmi is now FDA approved for treating tenosynovial giant cell tumor. This drug complements other rare tumor assets the Germany-based drugmaker has acquired in a series of business deals.

The post Drug Approval Marks Another Win for Merck KGaA’s Rare Tumor Strategy appeared first on MedCity News.

Read Entire Article

Start the new Vibrations with a Medbed Franchise today!

Protect your whole family with Quantum Orgo-Life® devices

Advertising by Adpathway